Literature DB >> 12799614

Increased expression of c-Jun transcription factor in cerebellar vermis of patients with schizophrenia.

Valentina K Todorova1, Alan D Elbein, Svetlana V Kyosseva.   

Abstract

In the cerebellar vermis of schizophrenic patients, our previous studies have revealed alterations in the mitogen-activated protein (MAP) kinase signaling cascade and downstream transcription factors within the c-fos promoter. Since the proteins of the Fos and Jun families of immediate-early genes dimerize to form activating protein (AP)-1, the present study was conducted to examine the expression of Jun transcription factors in schizophrenic and control subjects. Using Western blot analysis, we determined the protein levels of c-Jun, Jun B, and Jun D as well as the levels of c-jun mRNA by relative RT-PCR in post-mortem samples from cerebellar vermis. The expression of c-Jun protein and c-jun mRNA was significantly increased in the cerebellar vermis of patients with schizophrenia, whereas no significant differences were found in the expression of Jun B or Jun D proteins. Studies in rats indicated that the abnormal expression of c-Jun transcription factor observed in schizophrenic patients was not related to post-mortem intervals or chronic treatment with antipsychotic medications. This study provides new insights into cerebellar abnormalities of schizophrenia at the level of expression of c-Jun that target key genes associated with the MAP kinase cascade.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12799614     DOI: 10.1038/sj.npp.1300211

Source DB:  PubMed          Journal:  Neuropsychopharmacology        ISSN: 0893-133X            Impact factor:   7.853


  7 in total

1.  Increased G protein-coupled receptor kinase (GRK) expression in the anterior cingulate cortex in schizophrenia.

Authors:  Adam J Funk; Vahram Haroutunian; James H Meador-Woodruff; Robert E McCullumsmith
Journal:  Schizophr Res       Date:  2014-08-19       Impact factor: 4.939

2.  Regulation of ERK Kinase by MEK1 Kinase Inhibition in the Brain.

Authors:  Tara C Tassin; David R Benavides; Florian Plattner; Akinori Nishi; James A Bibb
Journal:  J Biol Chem       Date:  2015-05-13       Impact factor: 5.157

3.  The schizophrenia risk gene MIR137 acts as a hippocampal gene network node orchestrating the expression of genes relevant to nervous system development and function.

Authors:  Nikkie F M Olde Loohuis; Nael Nadif Kasri; Jeffrey C Glennon; Hans van Bokhoven; Sébastien S Hébert; Barry B Kaplan; Gerard J M Martens; Armaz Aschrafi
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2016-02-27       Impact factor: 5.067

4.  Abnormal activity of the MAPK- and cAMP-associated signaling pathways in frontal cortical areas in postmortem brain in schizophrenia.

Authors:  Adam J Funk; Robert E McCullumsmith; Vahram Haroutunian; James H Meador-Woodruff
Journal:  Neuropsychopharmacology       Date:  2011-11-02       Impact factor: 7.853

Review 5.  A Review of Biomarkers in Mood and Psychotic Disorders: A Dissection of Clinical vs. Preclinical Correlates.

Authors:  Sarel J Brand; Marisa Moller; Brian H Harvey
Journal:  Curr Neuropharmacol       Date:  2015       Impact factor: 7.363

6.  Exploring Transcription Factors-microRNAs Co-regulation Networks in Schizophrenia.

Authors:  Yong Xu; Weihua Yue; Yin Yao Shugart; Sheng Li; Lei Cai; Qiang Li; Zaohuo Cheng; Guoqiang Wang; Zhenhe Zhou; Chunhui Jin; Jianmin Yuan; Lin Tian; Jun Wang; Kai Zhang; Kerang Zhang; Sha Liu; Yuqing Song; Fuquan Zhang
Journal:  Schizophr Bull       Date:  2015-11-24       Impact factor: 9.306

7.  Altered gene expression in schizophrenia: findings from transcriptional signatures in fibroblasts and blood.

Authors:  Nadia Cattane; Alessandra Minelli; Elena Milanesi; Carlo Maj; Stefano Bignotti; Marco Bortolomasi; Luisella Bocchio Chiavetto; Massimo Gennarelli
Journal:  PLoS One       Date:  2015-02-06       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.